Moolec Science (MLEC) Total Debt (2023 - 2025)
Moolec Science (MLEC) reported Total Debt of $228.5 million for Q2 2025, down 36.84% on a YoY basis from $361.8 million in Q2 2024, and up 1079.55% sequentially from $19.4 million in Q4 2024.
Moolec Science (MLEC) Total Debt (2023 - 2025) Analysis & Trends
Moolec Science (MLEC) has 3 years of Total Debt data on file, last reported at $228.5 million in Q2 2025.
- For the quarter ending Q2 2025, Total Debt fell 36.84% year-over-year to $228.5 million; the trailing twelve-month figure through Jun 2025 stood at $228.5 million (down 36.84% YoY), and the FY2025 full-year result was $228.5 million, down 36.84% from the prior year.
- Total Debt climbed to $228.5 million in Q2 2025, from $19.4 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $361.8 million in Q2 2024 to a low of $1.2 million in Q1 2023.
- A 3-year average of $74.4 million and a median of $14.5 million in 2023 frame the typical range for Total Debt.
- Across the five-year window, Total Debt surged 2389.38% in 2024 and tumbled 36.84% in 2025, its largest moves.
- Tracing MLEC's Total Debt over 3 years: stood at $13.5 million in 2023, then soared by 43.88% to $19.4 million in 2024, then jumped by 1079.55% to $228.5 million in 2025.
- Business Quant data shows MLEC's Total Debt at $228.5 million in Q2 2025, $19.4 million in Q4 2024, and $18.2 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn | 959.06 Mn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | - |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 228.50 Mn |
| Dec 31, 2024 | 19.37 Mn |
| Sep 30, 2024 | 18.22 Mn |
| Jun 30, 2024 | 361.76 Mn |
| Mar 31, 2024 | 10.61 Mn |
| Dec 31, 2023 | 13.46 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 14.53 Mn |
| Mar 31, 2023 | 1.18 Mn |